Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe - Archive ouverte HAL Access content directly
Journal Articles Eurosurveillance Year : 2017

Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe

Abstract

We measured early 2016/17 season influenza vaccine effectiveness (IVE) against influenza A(H3N2) in Europe using multicentre case control studies at primary care and hospital levels. IVE at primary care level was 44.1%, 46.9% and 23.4% among 0–14, 15–64 and ≥ 65 year-olds, and 25.7% in the influenza vaccination target group. At hospital level, IVE was 2.5%, 7.9% and 2.4% among ≥ 65, 65–79 and ≥ 80 year-olds. As in previous seasons, we observed suboptimal IVE against influenza A(H3N2).
Fichier principal
Vignette du fichier
170.pdf (447.16 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Licence : CC BY - Attribution

Dates and versions

hal-03954015 , version 1 (24-01-2023)

Licence

Attribution

Identifiers

Cite

Esther Kissling, Marc Rondy, I-Move Study. Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe. Eurosurveillance, 2017, 22 (7), pp.30464. ⟨10.2807/1560-7917.ES.2017.22.7.30464⟩. ⟨hal-03954015⟩
31 View
14 Download

Altmetric

Share

Gmail Facebook X LinkedIn More